- Home
- IRT vs PCVX Comparison
IRT vs PCVX Comparison
Compare IRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- PCVX
- Stock Information
- Founded
- IRT 2009
- PCVX 2013
- Country
- IRT United States
- PCVX United States
- Employees
- IRT N/A
- PCVX N/A
- Industry
- IRT Real Estate Investment Trusts
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- IRT Real Estate
- PCVX Health Care
- Exchange
- IRT Nasdaq
- PCVX Nasdaq
- Market Cap
- IRT 3.8B
- PCVX 4.0B
- IPO Year
- IRT 2013
- PCVX 2020
- Fundamental
- Price
- IRT $16.35
- PCVX $41.81
- Analyst Decision
- IRT Buy
- PCVX Strong Buy
- Analyst Count
- IRT 7
- PCVX 8
- Target Price
- IRT $22.14
- PCVX $114.17
- AVG Volume (30 Days)
- IRT 3.3M
- PCVX 1.5M
- Earning Date
- IRT 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- IRT 4.16%
- PCVX N/A
- EPS Growth
- IRT N/A
- PCVX N/A
- EPS
- IRT 0.09
- PCVX N/A
- Revenue
- IRT $662,924,000.00
- PCVX N/A
- Revenue This Year
- IRT $4.19
- PCVX N/A
- Revenue Next Year
- IRT $4.72
- PCVX N/A
- P/E Ratio
- IRT $179.37
- PCVX N/A
- Revenue Growth
- IRT 3.70
- PCVX N/A
- 52 Week Low
- IRT $15.07
- PCVX $27.66
- 52 Week High
- IRT $22.26
- PCVX $107.31
- Technical
- Relative Strength Index (RSI)
- IRT 52.61
- PCVX 51.58
- Support Level
- IRT $15.99
- PCVX $39.87
- Resistance Level
- IRT $16.44
- PCVX $45.90
- Average True Range (ATR)
- IRT 0.36
- PCVX 1.93
- MACD
- IRT 0.07
- PCVX -0.60
- Stochastic Oscillator
- IRT 91.10
- PCVX 32.20
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.